المؤلفون: Yang Y; Department of Pediatrics (Children Hematological Oncology), Birth Defects and Childhood Hematological Oncology Laboratory, The Affiliated Hospital of Southwest Medical University, Sichuan Clinical Research Center for Birth Defects, Luzhou, Sichuan, China., Yang Y; Department of Pediatrics (Children Hematological Oncology), Birth Defects and Childhood Hematological Oncology Laboratory, The Affiliated Hospital of Southwest Medical University, Sichuan Clinical Research Center for Birth Defects, Luzhou, Sichuan, China., Shen Y; State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China., Liu J; Department of Pediatrics (Children Hematological Oncology), Birth Defects and Childhood Hematological Oncology Laboratory, The Affiliated Hospital of Southwest Medical University, Sichuan Clinical Research Center for Birth Defects, Luzhou, Sichuan, China., Zeng Y; Department of Pediatrics (Children Hematological Oncology), Birth Defects and Childhood Hematological Oncology Laboratory, The Affiliated Hospital of Southwest Medical University, Sichuan Clinical Research Center for Birth Defects, Luzhou, Sichuan, China., Wei C; State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China., Liu C; Department of Pediatrics (Children Hematological Oncology), Birth Defects and Childhood Hematological Oncology Laboratory, The Affiliated Hospital of Southwest Medical University, Sichuan Clinical Research Center for Birth Defects, Luzhou, Sichuan, China., Pan Y; Department of Pediatrics (Children Hematological Oncology), Birth Defects and Childhood Hematological Oncology Laboratory, The Affiliated Hospital of Southwest Medical University, Sichuan Clinical Research Center for Birth Defects, Luzhou, Sichuan, China., Guo Q; Department of Pediatrics (Children Hematological Oncology), Birth Defects and Childhood Hematological Oncology Laboratory, The Affiliated Hospital of Southwest Medical University, Sichuan Clinical Research Center for Birth Defects, Luzhou, Sichuan, China., Zhong F; Department of Pediatrics (Children Hematological Oncology), Birth Defects and Childhood Hematological Oncology Laboratory, The Affiliated Hospital of Southwest Medical University, Sichuan Clinical Research Center for Birth Defects, Luzhou, Sichuan, China., Guo L; Department of Pediatrics (Children Hematological Oncology), Birth Defects and Childhood Hematological Oncology Laboratory, The Affiliated Hospital of Southwest Medical University, Sichuan Clinical Research Center for Birth Defects, Luzhou, Sichuan, China., Liu W; Department of Pediatrics (Children Hematological Oncology), Birth Defects and Childhood Hematological Oncology Laboratory, The Affiliated Hospital of Southwest Medical University, Sichuan Clinical Research Center for Birth Defects, Luzhou, Sichuan, China.

المصدر: Pharmaceutical biology [Pharm Biol] 2023 Dec; Vol. 61 (1), pp. 259-270.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9812552 Publication Model: Print Cited Medium: Internet ISSN: 1744-5116 (Electronic) Linking ISSN: 13880209 NLM ISO Abbreviation: Pharm Biol Subsets: MEDLINE

مواضيع طبية MeSH: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/genetics , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/metabolism , Drugs, Chinese Herbal*/pharmacology, Humans ; Apoptosis ; Molecular Docking Simulation ; Network Pharmacology ; Signal Transduction ; T-Lymphocytes/metabolism ; Jurkat Cells

المؤلفون: Zhang X; Hebei Yanda Lu Daopei Hospital, Langfang, P.R. China.; Beijing Lu Daopei Institute of Hematology, Beijing, P.R. China., Wang T; Hebei Yanda Lu Daopei Hospital, Langfang, P.R. China.; Beijing Lu Daopei Institute of Hematology, Beijing, P.R. China., Zhang Y; Hebei Yanda Lu Daopei Hospital, Langfang, P.R. China., Wang F; Hebei Yanda Lu Daopei Hospital, Langfang, P.R. China., Chen J; Hebei Yanda Lu Daopei Hospital, Langfang, P.R. China., Ni J; Hebei Yanda Lu Daopei Hospital, Langfang, P.R. China., Sun R; Hebei Yanda Lu Daopei Hospital, Langfang, P.R. China.; Beijing Lu Daopei Institute of Hematology, Beijing, P.R. China., Wei Z; Hebei Yanda Lu Daopei Hospital, Langfang, P.R. China.; Beijing Lu Daopei Institute of Hematology, Beijing, P.R. China., Zhang G; Hebei Yanda Lu Daopei Hospital, Langfang, P.R. China., Li W; Hebei Yanda Lu Daopei Hospital, Langfang, P.R. China., Li J; Hebei Yanda Lu Daopei Hospital, Langfang, P.R. China.; Beijing Lu Daopei Institute of Hematology, Beijing, P.R. China., Lu P; Hebei Yanda Lu Daopei Hospital, Langfang, P.R. China.; Beijing Lu Daopei Institute of Hematology, Beijing, P.R. China.

المصدر: Leukemia & lymphoma [Leuk Lymphoma] 2023 Dec; Vol. 64 (13), pp. 2133-2139. Date of Electronic Publication: 2023 Sep 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

مواضيع طبية MeSH: Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/genetics , Receptors, Chimeric Antigen*/genetics, Humans ; Hematopoietic Stem Cell Transplantation ; Immunotherapy, Adoptive ; Retrospective Studies ; Translocation, Genetic

المؤلفون: Huang L; Department of hematology and oncology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, China., Zhu Y; Department of hematology and oncology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, China., Kong Q; Department of Hematology and Oncology, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China., Guan X; Department of hematology and oncology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, China., Lei X; Department of hematology and oncology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, China., Zhang L; Department of hematology and oncology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, China., Yang H; Department of hematology and oncology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, China., Yao X; Department of hematology and oncology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, China., Liang S; Department of hematology and oncology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, China., An X; Department of hematology and oncology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, China., Yu J; Department of hematology and oncology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, China.

المصدر: Cell adhesion & migration [Cell Adh Migr] 2023 Dec; Vol. 17 (1), pp. 1-14.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101469464 Publication Model: Print Cited Medium: Internet ISSN: 1933-6926 (Electronic) Linking ISSN: 19336918 NLM ISO Abbreviation: Cell Adh Migr Subsets: MEDLINE

مواضيع طبية MeSH: Integrin alphaVbeta3*/metabolism , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*, Humans ; T-Lymphocytes ; Phosphorylation ; MAP Kinase Signaling System

المؤلفون: Miller LH; Cancer and Blood Disorders Program, Children's Minnesota, Minneapolis, MN, USA., Maxa KL; Pharmacy, Children's Minnesota, Minneapolis, MN., Winter SS; Cancer and Blood Disorders Program, Children's Minnesota, Minneapolis, MN, USA., Gossai NP; Cancer and Blood Disorders Program, Children's Minnesota, Minneapolis, MN, USA.

المصدر: Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2023 Jul-Dec; Vol. 23 (12), pp. 1229-1236. Date of Electronic Publication: 2023 Dec 08.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101123358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8328 (Electronic) Linking ISSN: 14737140 NLM ISO Abbreviation: Expert Rev Anticancer Ther Subsets: MEDLINE

مواضيع طبية MeSH: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/chemically induced , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy , Lymphoma*/drug therapy, Humans ; Arabinonucleosides/adverse effects

المؤلفون: Ma Y; Center for Tumor Diagnosis and Therapy, Jinshan Hospital, Fudan University, Shanghai, China., Li Y; Center for Tumor Diagnosis and Therapy, Jinshan Hospital, Fudan University, Shanghai, China., Huang M; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China., Meng Y; Center for Tumor Diagnosis and Therapy, Jinshan Hospital, Fudan University, Shanghai, China.

المصدر: Journal of chemotherapy (Florence, Italy) [J Chemother] 2023 May; Vol. 35 (3), pp. 240-249. Date of Electronic Publication: 2022 Jun 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 8907348 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1973-9478 (Electronic) Linking ISSN: 1120009X NLM ISO Abbreviation: J Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Wnt Signaling Pathway* , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/genetics, Adult ; Humans ; Cell Line, Tumor ; Epigenesis, Genetic ; T-Lymphocytes

المؤلفون: Walcheck MT; Department of Surgery, Division of Surgical Oncology, University of Wisconsin School of Medicine and Public Health, K3/705 CSC, Madison, WI, USA., Nukaya M; Department of Surgery, Division of Surgical Oncology, University of Wisconsin School of Medicine and Public Health, K3/705 CSC, Madison, WI, USA., Ranheim EA; University of Wisconsin Carbone Cancer Center, Madison, WI, USA.; Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA., Matkowskyj KA; University of Wisconsin Carbone Cancer Center, Madison, WI, USA.; Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.; William S. Middleton Memorial Veterans Hospital, Madison, WI, USA., Ronnekleiv-Kelly S; Department of Surgery, Division of Surgical Oncology, University of Wisconsin School of Medicine and Public Health, K3/705 CSC, Madison, WI, USA.; University of Wisconsin Carbone Cancer Center, Madison, WI, USA.

المصدر: Leukemia & lymphoma [Leuk Lymphoma] 2023 Jun; Vol. 64 (6), pp. 1112-1122. Date of Electronic Publication: 2023 Apr 20.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

مواضيع طبية MeSH: Pancreatic Neoplasms*/genetics , Pancreatic Neoplasms*/metabolism , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/genetics, Animals ; Mice ; Mice, Transgenic ; Mutation ; Proto-Oncogene Proteins p21(ras)/genetics ; Proto-Oncogene Proteins p21(ras)/metabolism

المؤلفون: Liu Y; Pediatric Department, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Hubei, People's Republic of China., Zhang S; Pediatric Department, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Hubei, People's Republic of China., Tan Y; Pediatric Department, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Hubei, People's Republic of China.

المصدر: Hematology (Amsterdam, Netherlands) [Hematology] 2024 Dec; Vol. 29 (1), pp. 2337307. Date of Electronic Publication: 2024 Apr 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708388 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1607-8454 (Electronic) Linking ISSN: 10245332 NLM ISO Abbreviation: Hematology Subsets: MEDLINE

مواضيع طبية MeSH: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* , Allyl Compounds* , Biphenyl Compounds* , Phenols*, Humans ; Apoptosis ; Autophagy ; Cell Cycle Proteins ; RNA, Messenger ; Dexamethasone/pharmacology

المؤلفون: Thomas X; Hospices Civils de Lyon, Department of Clinical Hematology, Centre Hospitalier Lyon-Sud, Pierre Bénite, France.

المصدر: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2023 Jan; Vol. 32 (1), pp. 37-52. Date of Electronic Publication: 2022 Dec 28.

نوع المنشور: Review; Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7658 (Electronic) Linking ISSN: 13543784 NLM ISO Abbreviation: Expert Opin Investig Drugs Subsets: MEDLINE

مواضيع طبية MeSH: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma*, Child ; Adult ; Humans ; Immunotherapy/methods ; Prognosis ; T-Lymphocytes ; Immunotherapy, Adoptive/methods

المؤلفون: Liu X; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, PR China., Zou Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, PR China., Zhang L; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, PR China., Zhang Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, PR China., Chen Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, PR China., Chen X; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, PR China., Guo Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, PR China., Yang W; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, PR China., Zhu X; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, PR China.

المصدر: Leukemia & lymphoma [Leuk Lymphoma] 2022 Dec; Vol. 63 (14), pp. 3462-3474. Date of Electronic Publication: 2022 Sep 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

مواضيع طبية MeSH: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy, Child ; Humans ; Treatment Outcome ; Follow-Up Studies ; Antineoplastic Combined Chemotherapy Protocols ; Prognosis ; Recurrence ; China ; T-Lymphocytes ; Disease-Free Survival

المؤلفون: Singh K; Department of Hematology, Stem Cell Research Center, Sanjay Gandhi Post Graduate Institute Medical Sciences, Lucknow, India., Kumari S; Department of Biotechnology, Motilal Nehru National Institute of Technology Allahabad, Allahabad, India., Singh B; Department of Biotechnology, Motilal Nehru National Institute of Technology Allahabad, Allahabad, India., Choubey RB; Department of Biotechnology, Motilal Nehru National Institute of Technology Allahabad, Allahabad, India., Mitra DK; Department of Transplant Immunology and Immunogenetics, Cellular Immunology Laboratory, All India Institute of Medical Sciences, New Delhi, India., Rai AK; Department of Biotechnology, Motilal Nehru National Institute of Technology Allahabad, Allahabad, India.

المصدر: Cancer investigation [Cancer Invest] 2022 Sep; Vol. 40 (8), pp. 675-679. Date of Electronic Publication: 2022 Jul 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 8307154 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-4192 (Electronic) Linking ISSN: 07357907 NLM ISO Abbreviation: Cancer Invest Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia-Lymphoma, Adult T-Cell* , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*, Cell Line ; Humans ; Jurkat Cells